rouvax
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2007 (NCT00436007)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Measles virusImmunity, active
Measles virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rouvax
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01231503 | Phase 2 | Jan 1, 2011 | GlaxoSmithKline, PATH |
| NCT00820820 | N/A | Jan 1, 2009 | Government of France, Institut National de la Santé Et de la Recherche Médicale, France |
| NCT00436007 | Phase 2 | Apr 30, 2007 | GlaxoSmithKline |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 2 | 1 | 2007 |
| Government of France | Government | 1 | 0 | 1 | 2009 |
| Institut National de la Santé Et de la Recherche Médicale, France | Academic/Hospital | 1 | 1 | 1 | 2009 |
| PATH | Academic/Hospital | 1 | 0 | 1 | 2011 |
4 organizations
Page 1 / 1